TetraLogic Pharmaceuticals Corp (TLOG)

[TuesdaySmall]

Sponsor: National Cancer Institute (NCI) NCT03803774

Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma


https://clinicaltrials.gov/ct2/show/NCT03803774?term=Birinapant&rank=1